Home > News

UCI clears Chris Froome of salbutamol case

Decision comes one day after ASO tried to block Brit from Tour de France

Just one day after the ASO tried to prevent Chris Froome from racing the 105th Tour de France, the UCI has closed the salbutamol case against Sky’s Brit, exonerating him. The UCI announced on Monday that it “has considered all the relevant evidence in detail (in consultation with its own experts and experts from WADA)” and concluded that “Mr. Froome’s sample results do not constitute an AAF (adverse analytical finding)”. During the final week of last year’s Vuelta a España, which Froome won, his urine contained double the permitted level of salbutamol, 2000ng/ml.

Chris Froome, Sky and professional cycling has carried on this year under a cloud as there were questions as to whether he should be racing at all this season until the issue–leaked in early December 2017–was resolved. Did ASO’s move force UCI’s hand?

ASO dropped its effort to bar Froome from the race, but general director Christian Prudhomme was vexed by the situation.

Froome was relieved.

Some were exultant.

The UCI took a lot of heat for its rules and procedures during this case, and some thought its “let’s put this unpleasantness behind us” vibe hard to swallow.

The whole seven month case was a mess.

There’s no question now about Froome’s Vuelta and 2018 Giro d’Italia wins–there are no more asterisks. The World Anti Doping Association will not appeal the UCI’s decision. Froome will now try to win his fifth Tour de France, the cloud over him having lifted, but those dimming the light over all of professional cycling not entirely dissipated.